StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a research note published on Monday. The brokerage issued a sell rating on the medical research company’s stock.

By understanding how to calculate and interpret CAP rates, investors can make smarter, data-driven decisions when evaluating properties. Understanding CAP rates has helped me avoid bad deals ...